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Abstract
Background: Surgical interventions for the treatment of stress urinary incontinence (SUI) in women are commonly
employed following the failure of minimally invasive therapies. Due to the limited information available on the
relative cost-effectiveness of available surgeries for treating SUI, a de novo economic analysis was conducted to
assess costs and effects of all relevant surgeries. To inform the economic analysis, the objective of this review was
to identify and assess the quality of existing economic evaluation studies on different surgical interventions for the
treatment of SUI in women.
Methods: The following databases were searched during the review process: Medical Literature Analysis and
Retrieval System Online (MEDLINE), MEDLINE In-Process, Excerpta Medica Database (Embase), National Health
Service Economic Evaluation Database (NHS EED), and Health Management Information Consortium and Cost-
Effectiveness Analysis Registry (CEA registry). The key criteria for inclusion were that the study population included
women with SUI and that the surgical interventions considered were utilised as either a primary or a follow-up
surgery. The review included only full economic evaluations. Studies were quality assessed using the Drummond
checklist for economic evaluations. No quantitative synthesis of the results by meta-analysis was conducted due to
the high methodological heterogeneity.
Results: Twenty-six economic evaluations were included, of which 13 were model-based analyses. Surgical
treatments assessed most frequently were mid-urethral slings and open and laparoscopic colposuspension. There
were some differences in the methodological approaches taken, including differences in type of economic analysis,
perspective, time horizon, types of resource use, and costs and outcomes that were included in the analysis. The
majority of studies conducted a cost-utility analysis from a health system perspective and applied a time horizon of
between 1 and 5 years. The cost-effectiveness results suggest that single-incision mini-sling and mid-urethral slings
are among the most cost-effective options.
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Conclusions: The review has shown that methods used for the economic evaluation of surgical treatments for SUI
vary widely in terms of study design, analysis type, compared alternatives, time horizon, costing methodologies and
effect outcomes. Future economic evaluation studies on surgical treatments for SUI may be improved by the
application of available guidelines.
Systematic review registration: Registered in PROSPERO in 2016, CRD42016049339
Keywords: Systematic review, Economic evaluation, Surgical treatments, Stress urinary incontinence
Background
Stress urinary incontinence (SUI) is the involuntary leak-
age of urine due to any physical activity that puts pres-
sure on the bladder, such as exercising, sneezing,
coughing, laughing, or bending over [1]. SUI in women
is a distressing condition, which can reduce their quality
of life. Additionally, it can result in a large economic
burden. The prevalence of SUI in women varies from 20
to 50% over a lifetime but is seen more often in women
who have had children and in older women (above 40
years old) [2, 3]. Surgical treatment is usually recom-
mended when conservative treatments have failed to
control the condition [4]. Currently, there are various
different types of surgical treatments for SUI including
anterior vaginal repair or anterior colporrhaphy (anterior
repair), bladder neck needle suspensions (bladder neck
needle), open abdominal retropubic colposuspension
(open-colpo), laparoscopic retropubic colposuspension
(lap-colpo), traditional sub-urethral retropubic sling
(trad-sling), retropubic mid-urethral sling (retro-MUS),
transobturator mid-urethral sling (transob-MUS), single-
incision sling procedures (single-incision sling) and peri-
urethral injectable bulking agents (injectable agents).
Each of these surgeries can be conducted using different
techniques.
The various different types of surgical operations avail-
able, the different techniques used to perform these op-
erations and the lack of a consensus among surgeons
regarding which approach to use make it challenging to
establish which procedure should be used to treat SUI.
Although synthetic slings placed in a mid-urethral loca-
tion are now often regarded as the standard of care [5],
there is limited evidence that indicates that any one of
the aforementioned procedures should definitively be
used over the others based on safety, efficacy and cost-
effectiveness. Economic analyses are an important basis
for determining the cost-effectiveness of alternative
treatments and interventions. In order to be considered
useful for informing decision-making, there are certain
criteria that all economic evaluation studies should fulfil.
Any departure from these criteria means that results will
not be generalizable and the strength of the study find-
ings will be weakened [6]. A well-conducted economic
evaluation should consider all interventions routinely
used in the health system. The effect that an interven-
tion has on all relevant costs should be considered. This
includes not only the direct cost of the intervention, but
also its effect on healthcare costs and all the expendi-
tures incurred by patients. The costs relevant to the de-
cision makers and study perspective should be
considered when valuing costs. Where costs and benefits
occur beyond a 1-year time horizon, they should be dis-
counted to reflect the lower economic value of an ex-
pense that is delayed and the higher value of a benefit
that is realized earlier. The time horizon should be of
sufficient duration to capture all important differences
in costs and outcomes between the interventions being
compared. The clinical effectiveness estimates should be
based on a systematic review and meta-analysis of re-
sults from randomised clinical trials (RCTs), or at least a
single RCT, or, where this is not possible, appropriate
robust evidence. Data to estimate health-related quality
of life values should be reported by patients and/or
carers involved in the individual studies.
There are currently several economic evaluation stud-
ies that have been conducted to evaluate the cost-
effectiveness of different surgical treatments for SUI.
However, it is unclear if newly available treatments such
as retropubic mid-urethral sling, single-incision sling
and injectable bulking agents really result in equivalent
or better cost and health outcomes than older operations
that were previously available (such as anterior vaginal
repair or the different types of colposuspension). In
order to enable both evidence-based choices about surgi-
cal effectiveness and to allow impartial counselling of
women regarding the possible consequences of the alter-
native surgical operations for the management of SUI, it
is essential to collect reliable evidence in a systematic
and transparent manner. As part of a wider study ex-
ploring the effectiveness and cost-effectiveness of differ-
ent surgical treatments for SUI in women [7], a
systematic review of economic evidence was required.
The aims of this review were to provide a summary of
existing trial and model-based economic evaluation lit-
erature on currently available surgical interventions for
the treatment of SUI/stress-predominant mixed urinary
incontinence (MUI) (combination of SUI and urge urin-
ary incontinence (UUI)) in women and to highlight key
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strengths and weaknesses of the identified studies in
order to support future research.
Methods
Search strategy
The systematic review was conducted according to the
general principles of the Centre for Reviews and Dissem-
ination’s (CRD) guidance for undertaking reviews in
health care [8], the recommendations of the Cochrane
Handbook for Systematic Reviews [9] and the NICE
guide to the methods of technology appraisal [6] and
was reported according to the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA)
[10] (registered in PROSPERO in 2016,
CRD42016049339). The following databases were
searched during the review process: Medical Literature
Analysis and Retrieval System Online (MEDLINE),
MEDLINE In-Process (from 1946 to January 2017),
Excerpta Medica Database (Embase) (from 1974 to Janu-
ary 2017), National Health Service Economic Evaluation
Database (NHS EED) (until 2015; the database hasn’t
been updated since 2015), Health Management Informa-
tion Consortium (from 1979 to January 2017) and Cost-
Effectiveness Analysis Registry (CEA registry) (until
January 2017). All databases were searched using the
Ovid interface, except for the CEA registry which was
searched through the CEA registry website. The search
strategy used was tailored to each database (search terms
are provided in the Additional file 1: Table S1 and Table
S2). All searches were conducted in September 2016 and
were updated in January 2017.
Study eligibility
The key criteria for inclusion were that the study popu-
lation included SUI (either patients with SUI only or
stress-predominant MUI) and the surgical interventions
considered were utilised as either a primary or follow-up
surgery. The review included only full economic evalua-
tions (trial- and model-based) as they provide informa-
tion about costs and outcomes resulting from
implementing each intervention, and hence represent
the most relevant information for health care decision-
making. A full economic evaluation was defined as a
comparative study which included both costs and effects
for two or more surgical interventions. No restrictions
were placed on the publication timeframe or the study
country, but only English language studies were
included.
Study selection
Two reviewers (MJ, EM), with experience in health eco-
nomics, undertook the screening of titles and abstracts
obtained through the search. All potentially relevant arti-
cles were obtained for full-text screening against the
pre-defined selection criteria. Disagreements on the full-
text articles were resolved through discussion between
the two reviewers and, where necessary, by consulting a
third author from the core team to make a final
decision.
Data extraction
A standard form was developed to extract the data from
the included studies. The form was based on the Consol-
idated Health Economic Evaluation Reporting Standards
(CHEERS) checklist [11]. Data extracted included study
characteristics, country of study, target population, per-
spective of the economic evaluation, intervention and
comparator(s) details, cost year and currency, study de-
sign (i.e. trial-based/model-based/other), analysis type
(e.g. cost-effectiveness analysis (CEA), cost-utility ana-
lysis (CUA), cost-benefit analysis (CBA), cost-
minimization analysis (CMA), cost-consequence analysis
(CCA)), time horizon, model type and cycle length for
model-based studies, discounting, resource use included,
clinical effectiveness measure(s), quality of life mea-
sure(s), measure(s) of cost-effectiveness and type of sen-
sitivity analysis conducted. Data extraction was
undertaken by one reviewer, and all the extracted data
were verified by the second reviewer.
Quality assessment
As both trial- and model-based economic evaluation
studies were included in the review, the quality of the
economic evaluation studies was assessed using the
Drummond checklist [12]. This is the standard checklist
for reporting health economic evaluations, and it has
been recommended in the guidelines developed for eco-
nomic evaluation submissions to the BMJ. The quality
assessment was done by two reviewers.
Analysis
Meta-analysis was not conducted due to the high meth-
odological heterogeneity. However, for all studies that
reported total costs and quality-adjusted life-years
(QALYs), we converted the total cost from reported
values in the study (regardless of currency) to 2016 US$
using the EPPI-Centre Cost Converter [13]. The incre-
mental net monetary benefit (INMB) for each of the sur-
gical treatments was calculated as follows: incremental
benefit × threshold − incremental cost. The threshold
indicates the amount of money that each health system
is prepared to pay for each extra QALY gained through
different interventions. It was assumed that the thresh-
old was US$ 50 K in the base-case, and US$ 30–40 K
was assumed for sensitivity analyses. A positive INMB
indicates that the intervention is cost-effective compared
with the alterative at the given threshold. INMBs for
each intervention compared with different interventions,
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as well as the range of estimated total costs of each
intervention in different studies, are presented using for-
est plots.
Results
Literature search results
A total of 821 citations were identified from the original
search, with 732 remaining after de-duplication. Follow-
ing title and abstract screening, 97 studies remained.
Full-text copies of these 97 studies were obtained for
scrutiny against the full selection criteria and 71 were
excluded as they did not meet at least one of the inclu-
sion criteria. Reasons for exclusion included 11 were not
in the English language, 17 were not applicable to SUI/
stress-predominant MUI, 13 were not a full economic
evaluation and 30 were not evaluating a surgical treat-
ment. Therefore, 26 studies were included in the final
review. All studies were conducted in women with SUI
or MUI and included at least one of the surgical treat-
ments for SUI/stress-predominant MUI. A flow diagram
presenting the process of selecting studies can be found
in Fig. 1. An overview of the key data extracted from
these studies is presented in Table 1.
Basic characteristics of included studies
Seven studies were based in the US [14–20], six in the
UK [21–26], six in Canada [27–32], two in Spain [33,
34], one in Australia [35], one in Bosnia and
Herzegovina [36], one in Finland [37], one in Italy [38]
and one in the Netherlands [39]. Thirteen studies were
model-based analyses [14–23, 27–29], seven studies
were within-trial evaluations [24–26, 30, 31, 37, 38], five
were retrospective data analyses [32, 33, 35, 36, 40] and
one was prospective non-randomised study [34]. Of the
Fig. 1 PRISMA Flow diagram showing study selection for the economic evaluations review
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model-based studies, eight studies used a Markov model
[14, 15, 17, 19, 21–23, 27] and five used a decision tree
[16, 18, 20, 28, 29]. Sixteen studies were CUA [14–17,
19–26, 30, 31, 34, 38], four were CEA [28, 29, 32, 37],
four were CCA [18, 27, 35, 40], one was a CMA [33]
and one was a CBA [36]. Fifteen studies reported a
health service perspective [17, 19–22, 24–29, 32–34, 38],
two studies reported a societal perspective [14, 37], one
study reported a third-party payer perspective [16], two
studies reported a public payer perspective [30, 31] and
six studies did not report a perspective [15, 18, 23, 35,
36, 40]. One study reported a lifetime time horizon [14],
six studies reported a 10-year time horizon [15, 17–19,
21, 22], nine studies reported a 1-year time horizon [16,
20, 24, 28–30, 33, 34, 37], seven studies reported a 2–5
year time horizon [23, 25, 27, 31, 32, 38, 40] and one
study did not report a time horizon [35]. Retro-MUS or
transob-MUS were evaluated in 20 studies [14, 17, 19–
24, 26–31, 33, 36–38, 41, 42] either as intervention or
comparator, and 13 studies compared colposuspension
procedures (either open-colpo or lap-colpo) with each
other or other surgical treatments [18, 19, 22, 23, 25–27,
29, 32, 35, 37, 40, 41]. Four studies included injectable
agents as either an intervention or a comparator [20, 22,
28, 29], and two studies have included single-incision
sling [24, 33]. Other evaluated surgeries were trad-sling,
bladder neck needle, and vaginoplasty by Kelly.
Quality assessment
The completed Drummond checklist for the included
studies is presented in Table 2. All of the included stud-
ies had a well-defined question posed in an answerable
form and examined both the costs and effects of the al-
ternative options [14–38, 40]. Only six of the included
studies did not state a viewpoint for the analysis or place
the study in any particular decision-making context [15,
18, 23, 35, 36, 40]. Three studies did not provide a com-
prehensive description of the competing alternatives, or
only provided a comprehensive description of the inter-
vention without focussing sufficiently on the compara-
tor(s) [15, 17, 29]. Nineteen studies established the
effectiveness of the surgeries through a randomised con-
trolled clinical trial or systematic review of clinical evi-
dence [14–19, 21–31, 37, 38]. Of the studies that did
establish effectiveness, ten determined effectiveness
through a randomised controlled clinical trial [16, 23–
26, 29–31, 37, 38] and nine studies established effective-
ness through an overview of clinical studies [14, 15, 17–
19, 21, 22, 27, 28]. Seven studies used observational data
or assumptions to establish effectiveness [20, 32–36, 40].
Most of the included studies identified the important
and relevant costs and consequences of the alternatives
being compared, except for seven studies [14, 16, 32, 33,
35, 36, 40]. Costs and consequences were covered from
all relevant viewpoints (community or social viewpoint,
and those of patients and third-party payers) in only
three studies [14, 24, 37]. All of the included studies
measured costs and consequences accurately in appro-
priate physical units, except for six studies [18, 27, 33,
35, 36, 40]. All of the included studies valued costs cred-
ibly and clearly identified the sources of all values, ex-
cept for three studies where the sources of unit costs
were not clearly identified [29, 34, 36].
In eleven studies, costs and consequences were dis-
counted appropriately [14, 15, 17, 19, 21–23, 25, 27, 31,
32]. In 13 studies, this was not applicable as the time
horizon for the studies was ≤ 1 year. In one study, dis-
counting was not reported [35]. Of the studies that ap-
plied discounting, only four did not provide any
justification for the discount rate used [14, 22, 23, 27].
Six studies did not conduct an incremental analysis of
the costs and consequences of alternatives [18, 27, 33,
35, 36, 40]. Only four studies did not make allowance
for uncertainty in the estimates of costs and conse-
quences [21, 28, 35, 36]. Only in three studies were all
issues of concern to users and implementation discussed
[24–26]. In all of the studies, other than five [18, 27, 33,
35, 40], the conclusions of the analysis were based on
some overall index or ratio of costs to consequences.
Sixteen studies discussed the generalisability of the re-
sults to other settings and patient/client groups [14, 16–
19, 22, 24–29, 31, 34, 37]. Overall, included studies were
of modest to high quality, and at least 73% of studies (n
= 19) fulfilled nine out of ten criteria in the Drummond
checklist [12]. Results of the quality assessment are pro-
vided in Fig. 2.
Overall cost-effectiveness results
Cost-effectiveness results are summarized in the last col-
umn in Table 1. Briefly, there are five studies that have
compared tension-free vaginal tape (TVT) against open-
colpo or lap-colpo and all of them concluded that TVT
was more cost-effective than open-colpo [19, 22, 26, 37,
41]. All of these five studies were of high quality (Table
2). Two studies have compared TVT versus transobtura-
tor mid-urethral tape (TOT) [17, 30, 31]. The results
from these two studies show that TOT is cost-effective
compared with TVT. Two studies have compared
single-incision sling against tension-free vaginal obtur-
ator and both of them concluded that single-incision
sling is a cost-saving option compared to tension-free
vaginal obturator [24, 33]. While the study by Boyers
and colleagues [24] was of high quality, the study by
Castaneda and colleagues [33] did not meet most of the
Drummond checklist criteria, therefore was not a high
quality economic evaluation. Lap-colpo was compared
with open-colpo in three studies [25, 32, 35], and results
show that lap-colpo is likely to be more cost-effective
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than open-colpo, especially over the long-term. Inject-
able agents have been compared with retro-MUS or
transob-MUS in two studies [20, 28, 29], and results are
contradictory as results from the study by Kunkle and
colleagues [20] suggest that injectable agents are more
cost-effective than MUS over a 1-year time horizon,
while results from a study by Oremus and colleagues
[29] show that surgery may be more cost-effective than
collagen injections for the treatment of SUI. Overall, re-
sults of the economic evaluations suggest that single-
Table 2 Methodological quality assessment of economic evaluations using Drummond’s checklist
N/A not applicable
*1.Was a well-defined question posed in answerable form? 2. Was a comprehensive description of the competing alternatives given? 3. Was the effectiveness of
the programme or services established? 4. Were all the important and relevant costs and consequences for each alternative identified? 5. Were costs and
consequences measured accurately in appropriate physical units? 6. Were the cost and consequences valued credibly? 7. Were costs and consequences adjusted
for differential timing? 9. Was allowance made for uncertainty in the estimates of costs and consequences? 10. Did the presentation and discussion of study
results include all issues of concern to users?
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incision sling and retro-MUS or transob-MUS are
among the most cost-effective options followed by in-
jectable agents and lap-colpo. Calculated INMB for dif-
ferent surgical treatments are presented in Fig. 3 and in
Additional file 1: (Fig. S1 and Fig. S2). The range of esti-
mated total costs for each intervention is also presented
in Fig. 4.
Discussion
To our knowledge, this is the first systematic review of
the economic evidence on surgical treatments for SUI.
We systematically reviewed and assessed the quality of
26 economic evaluations comparing nine different surgi-
cal treatments for SUI. The studies differed in terms of
study design, analysis type, strategies compared, time
horizon, costing methodologies and effectiveness out-
comes. The surgical treatments assessed most frequently
were retro-MUS or transob-MUS, and open-colpo and
lap-colpo.
Although, as indicated in the results section, 73% of
the included studies fulfilled nine out of ten criteria
in the Drummond checklist [12], it could be argued
that this checklist does not necessarily capture all
components that are necessary for a methodologically
robust economic evaluation. For instance, issues
around time horizon of the analysis and the need to
capture costs and outcomes for as long as those af-
fected by the intervention are incurred are not con-
sidered in the Drummond checklist [12]. Similarly,
the checklist does not explicitly consider perspective
of the analysis among its criteria. In our own review,
the time horizons of the identified studies were gen-
erally of insufficient length, with only one of the in-
cluded studies assessing costs and consequences over
a lifetime time horizon [14]. The majority of studies
adopted ≤ 5 years’ time horizon which may not be of
sufficient length to capture all the associated costs
and effects of the surgical treatments. Only fifteen
studies (58%) reported a standard outcome of incre-
mental cost per QALY [14, 17, 19–26, 30, 31, 34, 38,
41, 42]. Furthermore, only two studies adopted the
societal perspective. When the societal perspective is
not used, it limits the generalizability of the cost-
effectiveness findings. In several studies, not all rele-
vant costs were included, which limits the applicabil-
ity of the results.
Traditionally, in the area of health economic evalu-
ation, a focus has been placed on ensuring that study as-
sumptions and cost and health outcome measurement
methodology have all been reported in a standardised
manner [12]. Although some of the studies identified
during this review included particular aspects of the
guidelines [12] and provided useful research findings re-
lated to surgical treatments of SUI, only three studies
(12%) were conducted entirely in accordance with the
relevant guidelines [12] based on the criteria that were
applicable. Based on results from this systematic review,
it can be concluded that despite years of work on the de-
velopment of guidelines for conducting and reporting
economic evaluations in health care, work still needs to
be done to ensure that future economic studies compar-
ing surgical treatments for SUI adopt appropriate meth-
odological approaches. This finding is consistent with
the hypothesis put forward by Zwolsman et al. who
claimed that economic evaluations in the area of stress
urinary incontinence are often of low quality, with poor
methodologies applied and inconsistent costing tech-
niques [43].
Fig. 2 Percentage of “Yes” for each question of Drummond’s 10-point checklist for assessing economic evaluations
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Differences in methodologies applied, and the spe-
cific focus of most research questions, as well as dif-
ferences in the reporting, design, assumptions, data
included and perspective of the analyses, mean that it
is difficult to say which of the alternative treatments
is most cost-effective. Nonetheless, the results from
the estimated INMB analysis suggest that single-
incision sling and mid-urethral sling are among the
most cost-effective options, followed by injectable
agents and lap-colpo. However, a more robust conclu-
sion on the cost-effectiveness of different surgical
treatments can only be reached when the relative
clinical effectiveness of all surgical treatments from
available RCTs are assessed within a network meta-
analysis and the results, along with other long-term
data, are used within an integrated decision analysis
model to estimate the comparative cost-effectiveness
of all the surgical treatments. This work was con-
ducted recently as part of the same UK study explor-
ing the clinical and cost-effectiveness of nine different
surgical treatments for stress urinary incontinence,
which led to the systematic review presented here. In
this study, a de novo economic analysis was con-
ducted, and single-incision sling and retro-MUS were
found to be the most cost-effective surgical interven-
tions [7].
Fig. 3 Incremental net monetary benefit for surgical interventions* (WTP = US$50 K). *Results are not based on a meta-analysis. INMB incremental
net monetary benefit; Lap-colpo laparoscopic retropubic colposuspension; Open_colpo open abdominal colposuspension; MUS mid-urethral sling;
SIMS single-incision mini-sling; ToT transobturator mid-urethral sling; TVO tension-free vaginal obturator; TVT tension-free vaginal tape
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Study limitations
As is the case with all systematic reviews, our study has
limitations, which need to be considered. First, we in-
cluded research published in English only and did not
look at grey literature. Second, meta-analysis was not
conducted due to the high heterogeneity among included
studies. This makes it challenging to compare results of dif-
ferent economic evaluations and give an overall conclusion
on the results. Instead, cost and effectiveness information
for each intervention was extracted and/or calculated from
those studies that had reported these values. Thirdly, any
potential conflicts of interest related to funding sources as-
sociated with included studies were not considered. Finally,
although a standard checklist (i.e. Drummond Checklist)
was used to assess the methodological quality of the in-
cluded studies, there are some issues that need to be
highlighted. Firstly, it only examines the quality of included
studies, and we were not able to judge the quality of report-
ing as this was beyond the scope of this review. Secondly,
the same weights are given to all criteria in the checklist.
One could argue that some items contribute more to po-
tential bias of results than other items. However, it is diffi-
cult to find reliable sets of weight for each of the items in
the checklist; therefore, this was not possible. Finally, as
highlighted earlier, while the Drummond checklist is a per-
fectly acceptable tool for assessing the methodological qual-
ity of economic evaluations, it does not explicitly consider
all issues of interest including time horizon and perspective
of the analysis.
Conclusions
This review identified the evidence base for economic
evaluation of surgical treatments for SUI and assessed and
highlighted the limitations and challenges of the included
Fig. 4 Estimated total costs* (2016 US$) for each intervention (circles indicate the number of papers/estimations). *Results are not based on a
meta-analysis. Lap-colpo laparoscopic retropubic colposuspension; Open_colpo open abdominal colposuspension; MUS mid-urethral sling; SIMS
single-incision mini-sling; ToT transobturator mid-urethral sling; TVT tension-free vaginal tape
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studies. This review has shown that there is wide variation
in terms of study design, analysis type, compared alterna-
tives, time horizon, costing methodologies and effect out-
comes among the included studies. The quality of future
health economic evaluation studies on surgical treatments
for SUI may be enhanced by the rigorous application of
quality guidelines, and the use of a societal perspective,
common cost categories and appropriate measurement of
health outcomes.
Take home messages
 There are a number of different surgical
interventions for the treatment of stress urinary
incontinence in women.
 A systematic review was conducted to explore the
evidence base of economic evaluations comparing
surgical treatments for the condition and to assess
their methodological quality.
 Twenty-six studies were included in the final review.
 Although 73% of the included studies fulfilled nine
out of ten criteria on the quality assessment
checklist used, there is scope for the methodological
quality of future economic evaluations in this area to
improve.
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